Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q2 FY25 results · Jul–Sep 2024
Acutaas Chemicals reported revenue from operations of ₹246.73 crore (up 43.2% from Q2 FY24) and net profit of ₹37.57 crore for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 246.73 | 172.36 | +43.2% | 176.67 | +39.7% |
| Other income | 8.44 | 1.50 | +461.7% | 1.04 | +709.2% |
| Total income | 255.17 | 173.86 | +46.8% | 177.71 | +43.6% |
| Profit before tax | 50.04 | (9.94) | Turned profit | 19.95 | +150.8% |
| Net profit for the period | 37.57 | (17.02) | Turned profit | 14.69 | +155.7% |
| Attributable to shareholders of the company | 37.33 | (18.85) | Turned profit | 13.95 | +167.7% |
| EPS, basic (₹) | 9.38 | (4.67) | not comparable | 3.67 | +155.6% |
| Net margin (%) | 15.2 | -9.9 | 8.3 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 243.59 | 163.60 | +48.9% | 171.14 | +42.3% |
| Other income | 8.58 | 1.26 | +581.1% | 1.90 | +352.1% |
| Total income | 252.17 | 164.86 | +53.0% | 173.03 | +45.7% |
| Profit before tax | 50.02 | (16.05) | Turned profit | 18.20 | +174.8% |
| Net profit for the period | 37.68 | (20.96) | Turned profit | 13.72 | +174.7% |
| EPS, basic (₹) | 9.41 | (5.75) | not comparable | 3.43 | +174.3% |
| Net margin (%) | 15.5 | -12.8 | 8.0 |
Consolidated
- Filed with BSE
- 29 Oct 2024, 17:25 IST
- Board meeting
- 29 Oct 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 Oct 2024, 17:25 IST
- Board meeting
- 29 Oct 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE